Posts by CNBC (old posts, page 55)
Nike said its fiscal fourth quarter will see the worst of its turnaround efforts, but investors are wondering if sales and profits still have more room to fall.
Nike says tariffs will cost it $1 billion before price increases, supply chain shifts
Nike said its fiscal fourth quarter will see the worst of its turnaround efforts, but investors are wondering if sales and profits still have more room to fall.
The $5 million Trump Card faces legal challenges, limited market
President Donald Trump is offering a $5 million path to citizenship for the wealthy with his Trump Card.
RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants
The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.
PayPal teams up with the Big Ten and Big 12 to enable payments to student-athletes
A new partnership between the Big Ten and Big 12 conferences and PayPal will allow student-athletes to receive their compensation via the fintech company.
Pixar's 'Elio' is emblematic of a bigger headwind for Hollywood
Disney and Pixar's "Elio" had a record low opening for the studio, but its performance is emblematic of a much wider trend in Hollywood: a reliance on sequels.
Family offices double down on private credit and infrastructure during private equity slump, survey finds
Investment firms of the ultra-rich are changing their portfolios for greater liquidity and less risk.
H&M shares jump as it flags summer shopping pick-up, says considering tariff price hikes
H&M's fiscal second quarter sales came in weaker-than-expected, though the world's second largest clothing retailer pointed to an uptick in summer demand.
Micron reports earnings, revenue beat and issues strong forecast
Micron reported earnings and revenue on Wednesday that exceeded analysts' estimates.
RFK Jr.'s CDC vaccine panel will review long-approved shots as skeptics gain sway
It is unclear how Kennedy's new members, including Dr. Robert Malone, will affect the panel's vaccine recommendations.